orforglipron vs semaglutide HUGE news in the GLP-1 space! has outperformed oral in the ACHIEVE-3 clinical trial in patients with type 2 diabetes. Comment your thoughts below! ⬇️ Eli Lilly's new anti-obesity pill

Figure 2 7 Translational and phenotype-informed implications of altered eating experience during GLP-1RA treatment GLP-1RA-associated changes in eating experience are clinically heterogeneous, and their significance is likely to vary according to individual susceptibility and stage of treatment

One element that distinguishes Ivim Health from many competitors in this space is that the company has published clinical outcomes data in a peer-reviewed journal - specifically Obesity Pillars , which is indexed on PubMed Central

Higher concentrations increase cost and formulation instability, so many brands dilute to levels that are safe but marginally effective

Both Alma TED and PRP are effective hair restoration treatments, but they work differently

Cirilo, M., Coccia, M.E., Attanasio, M and Fatini, C

What would you like to address